Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Accounts Payables: 2021-2025

Historic Accounts Payables for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $9.4 million.

  • Prime Medicine's Accounts Payables rose 72.30% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 72.30%. This contributed to the annual value of $11.4 million for FY2024, which is 41.90% down from last year.
  • As of Q3 2025, Prime Medicine's Accounts Payables stood at $9.4 million, which was up 46.66% from $6.4 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Accounts Payables peaked at $19.5 million during Q4 2023, and registered a low of $1.4 million during Q4 2021.
  • In the last 3 years, Prime Medicine's Accounts Payables had a median value of $9.4 million in 2025 and averaged $9.2 million.
  • Per our database at Business Quant, Prime Medicine's Accounts Payables spiked by 350.99% in 2023 and then tumbled by 61.56% in 2024.
  • Prime Medicine's Accounts Payables (Quarterly) stood at $1.4 million in 2021, then soared by 201.88% to $4.3 million in 2022, then surged by 350.99% to $19.5 million in 2023, then plummeted by 41.90% to $11.4 million in 2024, then spiked by 72.30% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q3 2025, $6.4 million for Q2 2025, and $10.0 million during Q1 2025.